Beltran Pedro has filed 5 insider transactions across 1 company since August 2025.
Most recent transaction: a grant/award of 1103837 shares of BridgeBio Oncology Therapeutics, Inc. ($BBOT) on May 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Beltran Pedro | President and CEO | A | Stock Option (Right to Buy) | 1103837 | $0.00 | 1,103,837.0000 | 79,988,687 | 9999.99% | 1.38% |
| April 1, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Beltran Pedro | President and CEO | F | Common Stock | 1047 | $9.03 | 45,623.0000 | 79,988,687 | 2.24% | 0.00% |
| March 10, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Beltran Pedro | Chief Scientific Officer | A | Common Stock | 46670 | $0.00 | 46,670.0000 | 79,988,687 | 9999.99% | 0.06% |
| March 10, 2026 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Beltran Pedro | Chief Scientific Officer | A | Stock Option (Right to Buy) | 210000 | $0.00 | 210,000.0000 | 79,988,687 | 9999.99% | 0.26% |
| Aug. 26, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Beltran Pedro | Chief Scientific Officer | A | Stock Option (Right to Buy) | 357177 | $0.00 | 357,177.0000 | 0 | 9999.99% | 0.00% |